本文へ移動
AiSeekAiSeek
サインイン

企業

Ono Pharmaceutical

フォロー構造マップを開くこれについて質問この企業をリサーチ

概要

本社
JP

Ono Pharmaceutical の構造

Ono Pharmaceutical

企業

関連 2 件
同業競合と提携
関係の開始2026
Ono Pharmaceutical企業 · 関連 2 件
第 1 層

同業競合と提携2

関係

矢印は関係の方向を示します。分野で絞り込めます。

  • Mediar Therapeuticsと提携 →Ono Pharmaceutical
    企業 · Mediar Therapeutics根拠 1
    事実90%
    証拠を見る
    • 企業開示PR Newswire news releases2026-10-07 19:08
      Mediar is also progressing novel fibro-inflammatory targets as part of a recently announced collaboration with Ono Pharmaceutical.
      出典を見る
  • Biohavenと協定 →Ono Pharmaceutical
    企業 · Biohaven根拠 1
    事実90%
    証拠を見る
    • 企業開示PR Newswire news releases2026-10-08 16:00
      Biohaven Ltd. together with its wholly owned subsidiaries, ("Biohaven") (NYSE: BHVN) today announced that it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd. ("Ono") (TYO: 4528)
      出典を見る
  • Biohavenと提携 →Ono Pharmaceutical
    企業 · Biohaven根拠 1
    事実90%
    証拠を見る
    • 企業開示PR Newswire news releases2026-10-08 16:00
      it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd.
      出典を見る

3 件中 1 から 3 件を表示

主張

出典とともに結論を確認し、項目を開いて証拠を読めます。

事実根拠 1
と協定Biohaven

Biohaven Ltd. together with its wholly owned subsidiaries, ("Biohaven") (NYSE: BHVN) today announced that it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd. ("Ono") (TYO: 4528)

PR Newswire news releases · 2026-10-08 16:00

証拠を見る
  • 企業開示PR Newswire news releases2026-10-08 16:00
    Biohaven Ltd. together with its wholly owned subsidiaries, ("Biohaven") (NYSE: BHVN) today announced that it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd. ("Ono") (TYO: 4528)
    出典を見る
事実根拠 1
と提携Biohaven

it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd.

PR Newswire news releases · 2026-10-08 16:00

証拠を見る
  • 企業開示PR Newswire news releases2026-10-08 16:00
    it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd.
    出典を見る
事実根拠 1
と提携Mediar Therapeutics

Mediar is also progressing novel fibro-inflammatory targets as part of a recently announced collaboration with Ono Pharmaceutical.

PR Newswire news releases · 2026-10-07 19:08

証拠を見る
  • 企業開示PR Newswire news releases2026-10-07 19:08
    Mediar is also progressing novel fibro-inflammatory targets as part of a recently announced collaboration with Ono Pharmaceutical.
    出典を見る

3 件中 1 から 3 件を表示

市場とバリュエーション

バリュエーションは Pro と Research で利用できます。

Pro で解放

利用できません: 企業シグナル · 財務 · 開示資料 · ガイダンス